Disclosure of Complementary and Alternative Medicine Use to Health Care Providers among HIV-Infected Women
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Gange, Stephen J.
Sharp, Gerald B.
Wilson, Tracey E.
Journal titleAIDS Patient Care and STDs
Publication Begin page965
Publication End page971
MetadataShow full item record
AbstractTo determine prevalence and predictors of complementary and alternative medicine (CAM) use disclosure to health care providers and whether CAM use disclosure is associated with highly active antiretroviral therapy (HAART) adherence among HIV-infected women, we analyzed longitudinal data collected between October 1994 and March 2002 from HIV-infected CAM-using women enrolled in the Women's Interagency HIV Study. Repeated measures Poisson regression models were constructed to evaluate associations of selected predictors with CAM use disclosure and association between CAM use disclosure and HAART adherence. A total of 1,377 HIV-infected women reported CAM use during study follow-up and contributed a total of 4,689 CAM-using person visits. The overall prevalence of CAM use disclosure to health care providers was 36% across study visits. Women over 45 years old, with a college education, or with health insurance coverage were more likely to disclose their CAM use to health care providers, whereas women identified as non-Hispanic Black or other ethnicities were less likely to communicate their CAM usage. More health care provider visits, more CAM domains used, and higher health care satisfaction scores had significant relationships with increased levels of CAM use disclosure. Restricting analysis to use of herbal or nonherbal medications only, similar results were obtained. Compared to other CAM domains, mind-body practice had the lowest prevalence of CAM use disclosure. Additionally, CAM use disclosure was significantly associated with higher HAART adherence. From this study, we showed that a high percentage of HIV-infected women did not discuss their CAM use with health care providers. Interventions targeted towards both physicians and patients may enhance communication of CAM use, avoid potential adverse events and drug interactions, and enhance HAART adherence.
CitationLiu C, Yang Y, Gange SJ, Weber K, Sharp GB, Wilson TE, Levine A, Robison E, Goparaju L, Gandhi M, Merenstein D. Disclosure of complementary and alternative medicine use to health care providers among HIV-infected women. AIDS Patient Care STDS. 2009 Nov;23(11):965-71. doi: 10.1089/apc.2009.0134. Erratum in: AIDS Patient Care STDS. 2009 Dec;23(12):1079. Ganhdi, Monica [corrected to Gandhi, Monica]. PMID: 19821723; PMCID: PMC2801553.
The following license files are associated with this item:
- Creative Commons
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivatives 4.0 International
- Association of complementary and alternative medicine use with highly active antiretroviral therapy initiation.
- Authors: Merenstein D, Yang Y, Schneider MF, Goparaju L, Weber K, Sharma A, Levine AM, Sharp GB, Gandhi M, Liu C
- Issue date: 2008 Sep-Oct
- Complementary and alternative medicine use decreases adherence to HAART in HIV-positive women.
- Authors: Owen-Smith A, Diclemente R, Wingood G
- Issue date: 2007 May
- A binational comparison of HIV provider attitudes towards the use of complementary and alternative medicine among HIV-positive Latino patients receiving care in the US-Mexico border region.
- Authors: Muñoz FA, Servin AE, Kozo J, Lam M, Zúñiga ML
- Issue date: 2013 Aug
- Association between complementary and alternative medicine use and adherence to highly active antiretroviral therapy in the Women's Interagency HIV Study.
- Authors: Liu C, Lerch V, Weber K, Schneider MF, Sharp GB, Gorapaju L, Sharma A, Levine A, Gandhi M, Merenstein D
- Issue date: 2007 Dec
- Use of complementary and alternative therapies by patients with human immunodeficiency virus disease in the era of highly active antiretroviral therapy.
- Authors: Bica I, Tang AM, Skinner S, Spiegelman D, Knox T, Gorbach S, Wilson IB
- Issue date: 2003 Feb